Securities litigation victory for Synergy Pharmaceuticals officers and directors
We secured a total victory for the clients, with all claims against them dismissed
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Securities class action win enforcing federal forum selection provision
We secured a dismissal for the clients
Complete victory for BT Group in securities fraud lawsuit
We secured a complete victory for BT when the Third Circuit affirmed the dismissal in full of the plaintiffs’ case
Securities litigation victory for XP
We secured a complete dismissal for the client
Securities litigation victory for Eletrobras
We secured a complete dismissal for the client
Victory for PwC China in putative class action
We secured a complete dismissal for PwC China in a lawsuit by Gridsum Holding shareholders
New York Court of Appeals victory for Morgan Stanley in RMBS case
On December 22, 2020, Davis Polk secured a victory for Morgan Stanley Mortgage Capital Holdings LLC (“Morgan Stanley”) in its appeal before the New York Court of Appeals stemming from a…
NYSE secures SEC approval of direct listing rule changes
Davis Polk successfully represented the New York Stock Exchange LLC (“NYSE”) before the Securities and Exchange Commission (the “SEC” or “Commission”) in connection with NYSE’s proposed…
Dismissal with prejudice of securities action against Uniti Group
On November 4, 2020, Chief Judge Leonard P. Stark of the U.S. District Court for the District of Delaware granted with prejudice a motion to dismiss filed by Davis Polk on behalf of…
NYSE asks SEC to lift stay of NYSE’s direct listing rule changes
On September 4, 2020, Davis Polk filed a motion with the Securities and Exchange Commission (the “SEC” or “Commission”) on behalf of the New York Stock Exchange LLC (“NYSE”) to lift an…